• Latest
  • Trending
  • All
  • Sport
  • Cricket
  • Odisha
Another Pharma Company Gets DCGI Nod To Launch COVID-19 Drug; Know The Price Per Dose

Another Pharma Company Gets DCGI Nod To Launch COVID-19 Drug; Know The Price Per Dose

6 years ago
KIIT school of rural management

KIIT School Of Rural Management Celebrates 20th Foundation Day; Verghese Kurien Seminar Hall Inaugurated

2 hours ago
TPSODL restoration

Cyclone Akvan: TPSODL Restores Power To 10.69 Lakh Consumers, Achieves Nearly 99% Restoration Within 7 Hours

2 hours ago
390 flap shell Turtles seized Malkangiri

390 Indian Flap-Shell Turtles Seized In Odisha’s Malkangiri

3 hours ago
blind cricket

Indian Cricket Team For Blind Walks Out Of Asia Cup Ceremony As Pakistan Handed Title Without A Ball Bowled

3 hours ago
Cyclone Akvan latest update

Cyclone Akvan Weakens Into Depression Over South Odisha, Likely To Further Lose Steam

3 hours ago
Years After Breakup, Lalit Modi Wishes Sushmita Sen On Her 51st Birthday

Years After Breakup, Lalit Modi Wishes Sushmita Sen On Her 51st Birthday

4 hours ago
Disability correction camp

Free Disability Correction Camp In Puri On November 22; Know How To Register

4 hours ago
3 Odisha doctors suspended

Odisha Suspends Three Doctors; Check Their Alleged Misconduct

4 hours ago
Nitish Bharadwaj Calls ‘Ramayana’ An ‘Agenda Film’, Wants Probe Into Its Massive Budget

Nitish Bharadwaj Calls ‘Ramayana’ An ‘Agenda Film’, Wants Probe Into Its Massive Budget

4 hours ago
Centurion University

Global Scholars Participate In ARC International Roundtable & 2nd Asia-Africa Dialogue At Odisha’s Centurion University

4 hours ago
Salman Khan Turns Chef On ‘Maatrubhumi’ Set, Makes Bhel For Crew

Salman Khan Turns Chef On ‘Maatrubhumi’ Set, Makes Bhel For Crew

5 hours ago
Rahul ‘Clueless On Geopolitics’: BJP Hits Back At ‘Compromised PM’ Jibe

Rahul ‘Clueless On Geopolitics’: BJP Hits Back At ‘Compromised PM’ Jibe

5 hours ago
  • Home
  • About us
  • Career
  • Contact
  • Privacy Policy
  • Terms of Usage
Saturday, November 21, 2026
No Result
View All Result
OdishaBytes
  • Home
  • Odisha
    • Policy & Politics
    • City
  • India
  • Sport
    • Cricket
    • Football
    • Hockey
    • IPL
  • Entertainment
    • Music
    • Movie Review
    • Television
    • Bollywood
    • Hollywood
    • Ollywood
  • Business
  • Lifestyle
    • Travel
    • Food
    • Health
    • fashion
  • World
  • More
    • News You Can Use
    • Good News
    • Viral Videos
    • Tech
      • Cars & Bikes
      • Mobile & Gadgets
      • Review
  • Home
  • Odisha
    • Policy & Politics
    • City
  • India
  • Sport
    • Cricket
    • Football
    • Hockey
    • IPL
  • Entertainment
    • Music
    • Movie Review
    • Television
    • Bollywood
    • Hollywood
    • Ollywood
  • Business
  • Lifestyle
    • Travel
    • Food
    • Health
    • fashion
  • World
  • More
    • News You Can Use
    • Good News
    • Viral Videos
    • Tech
      • Cars & Bikes
      • Mobile & Gadgets
      • Review
No Result
View All Result
OdishaBytes
No Result
View All Result
Home Virus Scare Coronavirus

Another Pharma Company Gets DCGI Nod To Launch COVID-19 Drug; Know The Price Per Dose

by OB Bureau
June 22, 2020
in Coronavirus, Featured
Reading Time: 2 mins read
Another Pharma Company Gets DCGI Nod To Launch COVID-19 Drug; Know The Price Per Dose
491
SHARES
1.4k
VIEWS
Share on FacebookShare on Twitter

New Delhi: Drug firm Hetero has received approval from Drug Controller General of India (DCGI) to manufacture and market antiviral drug Remdesivir for the treatment of COVID-19.

The DCGI has approved Remdesivir for treating adults and children, hospitalized with severe symptoms of the infectious disease.

ADVERTISEMENT

Hetero’s generic version of Remdesivir will be marketed under the brand name ‘Covifor’ in India, the company said in a statement. It will be available in 100 mg vial (injectable) and has to be administered intravenously under the supervision of a healthcare practitioner in a hospital, it added.

This comes a day after another India-based pharma firm Glenmark Pharmaceuticals launched antiviral drug FabiFlu for treatment of patients with mild to moderate COVID-19 symptoms.

“In the light of increasing Covid-19 cases in India, the approval of ‘Covifor’ (Remdesivir) can prove to be a game-changer given its positive clinical outcomes. Backed by strong backward integration capabilities, we can ensure that the product is immediately made available to patients across the country,” Chairman, Hetero Group of Companies, Dr B Partha Saradhi Reddy was quoted as saying by Hindustan Times.

Hetero Group of Companies MD Vamsi Krishna Bandi told PTI that the price of the drug will be in the range of Rs 5,000-6,000 per dose.

“The drug is being manufactured at the company’s formulation facility in Hyderabad. The active pharmaceutical ingredient (API) is being made in the firm’s Visakhapatnam facility,” he further said.

The company targets to provide one lakh doses in the next few weeks and ramp up production based on demand, he said, adding that the drug will not be available in the retail channel.

The medicine will be launched in the country under a licensing agreement with Gilead Sciences Inc. to expand access to affordable COVID-19 treatment in low and middle-income countries, the HT report added.

Tags: COVID-19DCGIDrug
Share196Tweet123
ADVERTISEMENT
Previous Post

SCB-Cuttack Achieves Another Milestone With 77th Bone Marrow Transplant Amid COVID-19 Scare

Next Post

Ganjam Reports 32 New COVID-19 Cases, Tally Crosses 900

OB Bureau

OB Bureau

Related Posts

Weakened Cyclone Akvan Nears Gopalpur Landfall; 90 Kmph Gusts Expected

Weakened Cyclone Akvan Nears Gopalpur Landfall; 90 Kmph Gusts Expected

by OB Bureau
November 20, 2026

Bhubaneswar: Cyclonic Storm Akvan, which had intensified into a severe cyclonic storm over the west-central Bay of Bengal, weakened overnight...

Extreme Rain & Storm Surge Alert: Senior IAS Officers Deployed In Coastal Dists As Odisha Braces For Cyclone Akvan Landfall

Extreme Rain & Storm Surge Alert: Senior IAS Officers Deployed In Coastal Dists As Odisha Braces For Cyclone Akvan Landfall

by OB Bureau
November 18, 2026

Bhubaneswar: Anticipating the landfall of Severe Cyclonic Storm Akvan along Andhra Pradesh-Odisha coast, the Mohan Majhi government has deputed four...

Oppn Uproar Over Floods, Kotia Disrupts Odisha Assembly Ahead Of Supplementary Budget

Oppn Uproar Over Floods, Kotia Disrupts Odisha Assembly Ahead Of Supplementary Budget

by OB Bureau
November 18, 2026

Bhubaneswar: The winter session of the Odisha Assembly commenced on a stormy note on Wednesday, with immediate pandemonium forcing Speaker...

Cyclone Akvan Shifts Track, Likely To Make Landfall Between Narsapur & Puri In Odisha

Cyclone Akvan Shifts Track, Likely To Make Landfall Between Narsapur & Puri In Odisha

by OB Bureau
November 18, 2026

Bhubaneswar: Severe Cyclonic Storm 'Akvan' has altered its projected trajectory and is now expected to cross the eastern coast between...

Next Post
Ganjam Reports 32 New COVID-19 Cases, Tally Crosses 900

Ganjam Reports 32 New COVID-19 Cases, Tally Crosses 900

OMC-Ad OMC-Ad OMC-Ad
SAI International School SAI International School SAI International School
OdishaBytes

Copyright © 2026 Frontier Media

Navigate Site

  • About
  • Advertise
  • Privacy & Policy
  • Contact
  • News Feed

Follow Us

No Result
View All Result
  • Home
  • Odisha
    • Policy & Politics
    • City
  • India
  • Sport
    • Cricket
    • Football
    • Hockey
    • IPL
  • Entertainment
    • Music
    • Movie Review
    • Television
    • Bollywood
    • Hollywood
    • Ollywood
  • Business
  • Lifestyle
    • Travel
    • Food
    • Health
    • fashion
  • World
  • More
    • News You Can Use
    • Good News
    • Viral Videos
    • Tech
      • Cars & Bikes
      • Mobile & Gadgets
      • Review

Copyright © 2026 Frontier Media